Risk and benefit of oral anticoagulants in atrial fibrillation
Zotova, I.V.; Zateĭshchikov, D.A.
Kardiologiia 51(10): 81-91
2011
ISSN/ISBN: 0022-9040 PMID: 22117686 Document Number: 654238
Thromboembolism is the main cause of death and disability of patients with atrial fibrillation. Indirect anticoagulants are effective means of primary and secondary prevention of thromboembolic complications. However in a number of patients risk associated with therapy with indirect anticoagulants might exceed potential benefit. The principle problem requiring solution in a patient with atrial fibrillation is individual comparative assessment of risk of development of thromboembolic and hemorrhagic complications. Modern stratification scales which allow solving this problem are considered in this review.
Document emailed within 1 workday
Related Documents
Lehto, M.; Mustonen, P.; Tierala, I. 2014: The use of direct oral anticoagulants (DOAC) in the treatment atrial fibrillation (AF) patients Duodecim; Laaketieteellinen Aikakauskirja 130(17): 1709-1717Scanziani, R.; Galassi, A. 2010: Treatment of atrial fibrillation in dialyzed patients: the role of oral anticoagulants. the nephrologist's point of view Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 27(3): 230-236
Chapurnykh, A.V.; Solov'ev, O.V.; Zavalin, A.V.; Pavlov, E.G.; Efremov, D.N. 2008: Nibentan in arresting acute atrial fibrillation: risk or benefit? Terapevticheskii Arkhiv 80(1): 41-45
Van Gennip, A.; Hellemons-Boode, B.; Krebber, T.; Langenberg-Ledeboer, M. 1992: Anticoagulants in non-rheumatic atrial fibrillation Nederlands Tijdschrift Voor Geneeskunde 136(4): 195-196
Forslund, T.; von Euler, M.; Johnsson, H.; Holmström, M.; Wettermark, B.ör.; Hjemdahl, P. 2015: More with atrial fibrillation, anticoagulants since the coming of NOAK Lakartidningen 112
Carlsäter, J.; Kristjansson, G.; Nilsson, G. 1994: Anticoagulants in non-valvular atrial fibrillation. a clinical dilemma in practice Lakartidningen 91(35): 3053-3056
Cox, J.L.; Schuessler, R.B.; Boineau, J.P. 1991: The surgical treatment of atrial fibrillation. I. Summary of the current concepts of the mechanisms of atrial flutter and atrial fibrillation Journal of Thoracic and Cardiovascular Surgery 101(3): 402-405
Tu, R-Hui.; Zhong, G-Qiang.; Zeng, Z-Yu.; Wu, W-Feng.; He, Y. 2011: A meta-analysis on efficacy of anti-platelet agents and anticoagulants for preventing stroke in patients with nonvalvular atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 39(3): 262-267
Steklov, V.I. 2013: Evaluation of risk factors for atrial fibrillation in patients with atrial flutter after radiofrequency ablation of cavotricuspid isthmus Voenno-Meditsinskii Zhurnal 334(2): 30-37
Cox, J.L.; Canavan, T.E.; Schuessler, R.B.; Cain, M.E.; Lindsay, B.D.; Stone, C.; Smith, P.K.; Corr, P.B.; Boineau, J.P. 1991: The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation Journal of Thoracic and Cardiovascular Surgery 101(3): 406-426
Ertas, F.; Oylumlu, M.; Akil, M.A.; Acet, H.; Bilik, M.Z.; Celepkolu, T.; Yildiz, A.; Kaya, H.; Alan, S.; Ozhan, H. 2013: Non-valvular atrial fibrillation in the elderly; preliminary results from the National AFTER (Atrial Fibrillation in Turkey: Epidemiologic Registry) Study European Review for Medical and Pharmacological Sciences 17(8): 1012-1016
Wu, G.; Jiang, H.; Huang, C.-x.; Yang, B.; Huang, H.; Wang, Y.-l.; Wang, X.-h.; Liu, H.-f.; Yang, X.-h. 2008: Effects of antiarrhythmic drug use on atrial fibrillation recurrence in atrial fibrillation patients post circumferential pulmonary vein ablation Zhonghua Xin Xue Guan Bing Za Zhi 36(7): 623-626
Wen, S.; Liu, N.; Li, S.; Ning, M.; Kang, J.; Wu, J.; Ruan, Y.; Jiang, C.; Sang, C.; Tang, R.; Long, D.; Yu, R.; Bai, R.; Du, X.; Hu, R.; Dong, J.; Liu, X.; Ma, C. 2015: Predictors of atrial fibrillation recurrence after catheter ablation in hypertrophic cardiomyopathy patients with atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 43(7): 589-594
Gianetti, J.; Gensini, G.; De Caterina, R. 1998: A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants Thrombosis and Haemostasis 80(6): 887-893
Charantharayil Gopalan, B.; Namboodiri, N.; Abdullakutty, J.; Lip, G.Y.; Koshy, A.G.; Krishnan Nair, V.; Babu, S.; Muhammed, S.; Azariah, J.L.; George, R.; Nambiar, A.; Govindan, U.; Zachariah, G.; Kumaraswamy, N.; Chakanalil Govindan, S.; Natesan, S.; Roby, A.; Velayudhan Nair, K.; Pillai, A.M.; Daniel, R.; Jayagopal, P.B.; Punnose, E.; Joseph, J.; Joseph, S.; Eapen, K.; Ram, R.; Mathew, C.; Faizal, A.; Issac, B.; Renga, S.; Menon, J.; Harikrishna, D.; Suresh, K.; Nair, T.; Susanth, S.S.; Kumar, R.A.; Abilash, T.P.; Sreekala, P.; Rajeev, E.; Raj, A.; Naik, R.; Rajalekshmi; Gopinath, A.; Binu, R.; Chacko, J.; Iqbal, P.T.; Sudhir, N.M.; Sreedharan, M.; Balakrishnan, N.; Musthaffa, M.; Jayakumar, B.; George, S.; Kumar, A.; Mathew, T.; Pramod, 2019: Kerala Atrial Fibrillation Registry: a prospective observational study on clinical characteristics, treatment pattern and outcome of atrial fibrillation in Kerala, India, cohort profile Bmj Open 9(7): E025901
Capucci, A.; Rosi, A.; Villani, G.Q.; Aschieri, D.; Piepoli, M. 1998: Class-1C drugs for oral loading in the cardioversion of paroxysmal atrial fibrillation Giornale Italiano di Cardiologia 28(12): 1422-1430
2006: Device may reduce stroke risk from chronic atrial fibrillation Mayo Clinic Health Letter 24(1): 4
Ecker-Schlipf, B. 2008: Atrial fibrillation. Pulse pressure as an important risk factor Medizinische Monatsschrift für Pharmazeuten 31(4): 153
Cheng, T.O. 2002: Preoperative beta-blockade and risk of postoperative atrial fibrillation JAMA 288(5): 573; Author Reply 573-4
Di Pasquale, G.; Urbinati, S.; Ribani, M.A.; Passarelli, P.; Pinelli, G. 1994: Clinical markers of embolic risk in patients with atrial fibrillation Giornale Italiano di Cardiologia 24(3): 315-324